Axoft raises $55m to advance BCI made of Fleuron
Summary
The funds will advance Axoft’s existing clinical trial programmes and progress US regulatory activities for its implantable brain-computer interface.
Description
The funds will advance Axoft’s existing clinical trial programmes and progress US regulatory activities for its implantable brain-computer interface.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source